No ano passado, Retractable Technologies Inc gerou US$ 24.91M em seu segmento de melhor desempenho, Syringes. A região United States teve a maior contribuição, com US$ 32.24M no período. No último trimestre, Retractable Technologies Inc registrou receita de US$ 6.25M no período encerrado em 2026-06-30, proveniente principalmente do segmento Syringes. A região United States teve a maior contribuição, com receita de US$ 5.87M.

Por Empresa

Receita

Proporção

Anual

Anual

Trimestral

Syringes

EasyPoint Needles

Blood Cllection Products

Other Products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Syringes

24.91M(65.10%)

22.63M(68.47%)

34.16M(78.34%)

86.74M(91.48%)

176.33M(93.60%)

68.73M(83.96%)

35.64M(85.27%)

28.27M(84.95%)

EasyPoint Needles

11.94M(31.21%)

8.95M(27.08%)

7.25M(16.63%)

4.67M(4.93%)

9.64M(5.12%)

9.63M(11.76%)

2.98M(7.13%)

3.41M(10.26%)

Blood Cllection Products

1.37M(3.58%)

1.43M(4.31%)

1.93M(4.42%)

2.95M(3.12%)

2.25M(1.19%)

2.36M(2.89%)

2.72M(6.50%)

1.42M(4.28%)

Other Products

43.63K(0.11%)

45.85K(0.14%)

266.27K(0.61%)

451.95K(0.48%)

167.56K(0.09%)

1.14M(1.39%)

464.05K(1.11%)

172.41K(0.52%)

Por Região

Receita

Proporção

Anual

Anual

Trimestral

United States

North and South America(excluding U.S)

Other International

Sales to U.S. government

HHS Order sales to U.S. Government

North and South America sales

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

32.24M(84.24%)

29.37M(88.88%)

34.60M(79.36%)

36.49M(38.49%)

53.89M(28.61%)

42.17M(51.51%)

31.90M(76.32%)

28.65M(86.09%)

27.02M(78.32%)

26.31M(88.20%)

23.03M(77.93%)

27.65M(80.10%)

24.84M(80.70%)

25.36M(75.39%)

26.66M(83.03%)

North and South America(excluding U.S)

5.06M(13.22%)

1.96M(5.93%)

6.09M(13.96%)

29.13M(30.72%)

14.56M(7.73%)

6.89M(8.42%)

8.25M(19.74%)

3.60M(10.81%)

--(--)

Other International

968.61K(2.53%)

1.71M(5.19%)

2.91M(6.68%)

13.47M(14.20%)

6.27M(3.33%)

1.17M(1.42%)

1.65M(3.95%)

1.03M(3.10%)

1.10M(3.18%)

776.87K(2.60%)

853.44K(2.89%)

1.22M(3.53%)

1.49M(4.84%)

3.61M(10.74%)

710.16K(2.21%)

Sales to U.S. government

--(--)

15.73M(16.59%)

113.66M(60.34%)

--(--)

HHS Order sales to U.S. Government

--(--)

31.63M(38.64%)

--(--)

North and South America sales

--(--)

6.38M(18.50%)

2.74M(9.19%)

5.67M(19.18%)

5.65M(16.37%)

4.45M(14.47%)

4.67M(13.88%)

4.74M(14.75%)